Oral Pretreatment with Ebselen Enhances Heat Shock Protein 72 Expression and Reduces Myocardial Infarct Size
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Reactive oxygen species (ROS) enhance myocardial ischemia-reperfusion (I/R) injury. Ebselen, a seleno-organic glutathione peroxidase (GPx) mimetic, has a protective effect against tissue injury induced by ROS. However, the cardio-protective effect of orally administered ebselen has never been investigated in cardiac I/R injury. We investigated the effects and mechanisms of orally administered ebselen on experimental myocardial infarction. Isolated perfused rabbit hearts underwent 30 min of global ischemia and 60 min of reperfusion, with or without oral administration of ebselen 24 h before I/R, with or without enhanced oxidative stress by H202 infusion for the first 1 min of reperfusion. The recovery of left ventricular developed pressure (LVDP) was significantly improved, and the myocardial infarct size was significantly reduced by ebselen. The recovery of LVDP and the myocardial infarct size were markedly aggravated by H202 infusion. These enhancements by H202 were dose-dependently suppressed by ebselen, along with a reduction in myocardial 8-hydroxydeoxyguanosine levels, a marker for oxidative DNA damage. The myocardial reduced glutathione (GSH) level was preserved by ebselen. Ebselen markedly enhanced myocardial heat shock protein (HSP) 72 expression. The cardioprotective effect of ebselen-induced HSP72 was confirmed by MTT assay in isolated cardiomyocytes using KNK437, a novel HSP inhibitor. In conclusion, an oral administration of ebselen 24 h before I/R provided excellent cardioprotective effects, at least in part through HSP72 induction and GSH preservation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Protection against peroxynitrite
Arteel, G. E., Briviba, K., & Sies, H. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00073-3 · Cited by 305
Mitochondrial changes associated with glutathione deficiency
Meister, A. (1995) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(95)00007-q · Cited by 242 · cited 1×
“More importantly, it has been reported that GSH synthesis is impaired (30, 31, 33, 34), and the activity of γ-glutamylcysteine synthetase (GGCS), a rate-limiting enzyme in GSH biosynthesis, is decreased in I/R (32).”
BackgroundBrown, J. M., Terada, L. S., Grosso, M. A., Whitmann, G. J., Velasco, S. E., Patt, A., Harken, A. H., & Repine, J. E. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113448 · Cited by 137 · cited 9×
“Ebselen, a seleno- organic glutathione peroxidase (GPx) mimetic, has a protective effect against tissue injury induced by ROS.”
BackgroundInfluential
Cited by
Selenium: its role as antioxidant in human health
Tinggi, U. (2008) · Environmental Health and Preventive Medicine · doi:10.1007/s12199-007-0019-4 · Cited by 607
Battin, E. E., & Brumaghim, J. L. (2009) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-009-9054-7 · Cited by 476
Ebselen, a promising antioxidant drug: mechanisms of action and targets of biological pathways
Azad, G. K., & Tomar, R. S. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3417-x · Cited by 343
Cardiovascular diseases: protective effects of melatonin
Tengattini, S., Reiter, R. J., Tan, D., Terron, M. P., Rodella, L. F., & Rezzani, R. (2008) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2007.00518.x · Cited by 337
Maes, M., Ruckoanich, P., Chang, Y. S., Mahanonda, N., & Berk, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.06.008 · Cited by 169
“, 1984), has cardioprotective effects (Baljinnyam et al., 2006); alleviates cardiomyopathies (Saad et al.”
BackgroundHort, M. A., Straliotto, M. R., de Oliveira, J., Amoêdo, N. D., da Rocha, J. B. T., Galina, A., Ribeiro-do-Valle, R. M., & de Bem, A. F. (2014) · Biochimie · doi:10.1016/j.biochi.2014.07.004 · Cited by 27
Metadata
- Authors
- BALJINNYAM, E., HASEBE, N., MORIHIRA, M., SUMITOMO, K., MATSUSAKA, T., FUJINO, T., FUKUZAWA, J., USHIKUBI, F., & KIKUCHI, K.
- Venue
- Hypertension Research
- Publisher
- Japanese Society of Hypertension
- Published
- 2006
- Volume
- 29
- Issue
- 11
- Pages
- 905-913
- ISSN
- 0916-9636 (ISSN-L)
- 1348-4214
- OpenAlex
- W1990706007
- Cited by
- 35
- References
- 3
- FWCI
- 1.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.